Soukup, Klara <br/><br/>
The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Jul 2015 
 - 541-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1401663  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Differentiation<br/>Dendritic Cells--drug effects<br/>Encephalomyelitis, Autoimmune, Experimental--genetics<br/>Gene Expression Regulation<br/>Humans<br/>Immunization<br/>Interleukin-10--genetics<br/>Interleukin-12--genetics<br/>Interleukin-1alpha--genetics<br/>Interleukin-1beta--genetics<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Lipopolysaccharides--administration & dosage<br/>Lymph Nodes--drug effects<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Mitogen-Activated Protein Kinase 1--genetics<br/>Mitogen-Activated Protein Kinase 3--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>STAT3 Transcription Factor--genetics<br/>Signal Transduction<br/>Th1 Cells--drug effects<br/>p38 Mitogen-Activated Protein Kinases--genetics